Advancing precision oncology: Insights into the tumor microenvironment and immunotherapy outcomes
Innovation (Camb)
.
2024 Jun 7;5(4):100656.
doi: 10.1016/j.xinn.2024.100656.
eCollection 2024 Jul 1.
Authors
Tomotaka Ugai
1
2
3
,
Qian Yao
1
,
Satoko Ugai
1
2
,
Shuji Ogino
1
2
4
5
6
Affiliations
1
Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA.
2
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
3
Cancer Epidemiology Program, Dana-Farber/Harvard Cancer Center, Boston, MA 02215, USA.
4
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
5
Cancer Immunology Program, Dana-Farber/Harvard Cancer Center, Boston, MA 02215, USA.
6
Tokyo Medical and Dental University (Institute of Science Tokyo), Bunkyo, Tokyo 1138510, Japan.
PMID:
39021526
PMCID:
PMC11253650
DOI:
10.1016/j.xinn.2024.100656
No abstract available
Publication types
Review